Last reviewed · How we verify

NCT05389007: RGTTP

.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

Status unknown Last updated 24 May 2022
What this trial tests

trial in Thrombotic Thrombocytopenic Purpura in 156 participants. Status unknown.

Timeline
8 July 2016
Primary endpoint
1 July 2025

Quick facts

Lead sponsorJohannes Gutenberg University Mainz
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment156
Start date8 July 2016
Primary completion1 July 2025
Sites1 location across Germany

Conditions studied

Sponsor

Johannes Gutenberg University Mainz

Who can join

18 and older, any sex, with Thrombotic Thrombocytopenic Purpura. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Open, multi-center, observational, prospective cohort study, only disease-indicated treatment, in patients with clinically diagnosed acquired and congenital TTP regardless of gender, ethnicity, and comorbidities, over the age of 18 for 1.) prospective investigation of patients with TTP in an acute bout and during long-term follow and 2.) assessment of prevalence, course of disease, success of therapy, possible triggers for relapses and possibilities for better diagnosis and prognosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Thrombotic Thrombocytopenic Purpura

Currently open trials in the same condition.

Other Johannes Gutenberg University Mainz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389007.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing